Literature DB >> 17720156

14-3-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase.

Emi Mizuno1, Naomi Kitamura, Masayuki Komada.   

Abstract

The deubiquitinating enzyme UBPY, also known as USP8, regulates cargo sorting and membrane traffic at early endosomes. Here we demonstrate the regulatory mechanism of the UBPY catalytic activity. We identified 14-3-3 epsilon, gamma, and zeta as UBPY-binding proteins using co-immunoprecipitation followed by mass spectrometric analysis. The 14-3-3 binding of UBPY was inhibited by mutating the consensus 14-3-3-binding motif RSYS(680)SP, by phosphatase treatment, and by competition with the Ser(680)-phosphorylated RSYS(680)SP peptide. Metabolic labeling with [(32)P]orthophosphate and immunoblotting using antibody against the phosphorylated 14-3-3-binding motif showed that Ser(680) is a major phosphorylation site in UBPY. These results indicated that 14-3-3s bind to the region surrounding Ser(680) in a phosphorylation-dependent manner. The mutation at Ser(680) led to enhanced ubiquitin isopeptidase activity of UBPY toward poly-ubiquitin chains and a cellular substrate, epidermal growth factor receptor, in vitro and in vivo. Moreover, addition of 14-3-3epsilon inhibited the UBPY activity in vitro. Finally, UBPY was dephosphorylated at Ser(680) and dissociated from 14-3-3s in the M phase, resulting in enhanced activity of UBPY during cell division. We conclude that UBPY is catalytically inhibited in a phosphorylation-dependent manner by 14-3-3s during the interphase, and this regulation is cancelled in the M phase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720156     DOI: 10.1016/j.yexcr.2007.07.028

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  35 in total

Review 1.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

2.  The deubiquitinating enzyme USP8 promotes trafficking and degradation of the chemokine receptor 4 at the sorting endosome.

Authors:  Ilana Berlin; Katherine M Higginbotham; Rebecca S Dise; Maria I Sierra; Piers D Nash
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

Review 3.  Reverse the curse--the role of deubiquitination in cell cycle control.

Authors:  Ling Song; Michael Rape
Journal:  Curr Opin Cell Biol       Date:  2008-03-17       Impact factor: 8.382

Review 4.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

Authors:  Francisca E Reyes-Turcu; Karen H Ventii; Keith D Wilkinson
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

5.  Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.

Authors:  Yunjung Kim; Aya Shiba-Ishii; Tomoki Nakagawa; Shun-Ichiro Iemura; Tohru Natsume; Noriyuki Nakano; Ryota Matsuoka; Shingo Sakashita; SangJoon Lee; Atsushi Kawaguchi; Yukio Sato; Masayuki Noguchi
Journal:  Oncogene       Date:  2018-06-07       Impact factor: 9.867

Review 6.  Breaking the chains: structure and function of the deubiquitinases.

Authors:  David Komander; Michael J Clague; Sylvie Urbé
Journal:  Nat Rev Mol Cell Biol       Date:  2009-08       Impact factor: 94.444

7.  The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.

Authors:  Luis G Perez-Rivas; Marily Theodoropoulou; Francesco Ferraù; Clara Nusser; Kohei Kawaguchi; Constantine A Stratakis; Fabio Rueda Faucz; Luiz E Wildemberg; Guillaume Assié; Rudi Beschorner; Christina Dimopoulou; Michael Buchfelder; Vera Popovic; Christina M Berr; Miklós Tóth; Arif Ibrahim Ardisasmita; Jürgen Honegger; Jerôme Bertherat; Monica R Gadelha; Felix Beuschlein; Günter Stalla; Masayuki Komada; Márta Korbonits; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2015-05-05       Impact factor: 5.958

8.  Synaptic strength is bidirectionally controlled by opposing activity-dependent regulation of Nedd4-1 and USP8.

Authors:  Samantha L Scudder; Marisa S Goo; Anna E Cartier; Alice Molteni; Lindsay A Schwarz; Rebecca Wright; Gentry N Patrick
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

Review 9.  Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside.

Authors:  Anat Ben-Shlomo; Odelia Cooper
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-08       Impact factor: 3.243

10.  Proteomic analysis of 14-3-3 zeta binding proteins in the mouse hippocampus.

Authors:  Maura Heverin; Gary P Brennan; Christian J Koehler; Achim Treumann; David C Henshall
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.